Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03784716 · ClinicalTrials.gov registry record · NA
Ketogenic Diet in Non-alcoholic Fatty Liver Disease
A NA study, sponsored by Marc Goodman.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03784716 is a NA study that has completed, run by Marc Goodman. The registered enrollment target is 24 participants.
The verdict
NCT03784716, a NA study, has completed, sponsored by Marc Goodman.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this randomized trial is to examine the effects of a ketogenic diet on non-alcoholic fatty liver disease (NAFLD). Twenty-four participants with NAFLD will be randomized to receive a ketogenic meal plan or control (standard weight loss meal plan). Participants will be followed up to 28 days after initiation of the diet intervention.
Interventions
- OTHER Ketogenic Diet
- OTHER Standard Weight Loss Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03784716
The ClinicalTrials.gov registry entry for NCT03784716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marc Goodman, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketogenic Diet is the first listed.
NCT03784716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03784716 about?
NCT03784716 is a clinical study titled "Ketogenic Diet in Non-alcoholic Fatty Liver Disease". The purpose of this randomized trial is to examine the effects of a ketogenic diet on non-alcoholic fatty liver disease (NAFLD). Twenty-four participants with NAFLD will be randomized to receive a ketogenic meal plan or control (standard weight loss meal plan). Participants will be followed up to 28...
What is the current status of trial NCT03784716?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-03-13. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT03784716?
The interventions under investigation include: Ketogenic Diet (OTHER), Standard Weight Loss Diet (OTHER).
Who is sponsoring clinical trial NCT03784716?
This trial is sponsored by Marc Goodman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.